Advanced Magnetics Inc., of Cambridge, Mass., added Mark Skaletsky and Theodore Steinman to its board.

Advanced Viral Research Corp., of Yonkers, N.Y., retained James D'Olimpio, who will serve the company in a consulting role and on its scientific advisory board.

AEterna Laboratories Inc., of Quebec City, Quebec, appointed Henri Roy and Francis Bellido to its board.

Amersham plc, of London, appointed Peter Loescher chief operating officer.

Aurora Funds in Research Triangle Park, N.C., promoted Doug Gooding to president of Regado BioSciences.

Columbia Laboratories Inc., of Livingston, N.J., named George Creasy vice president, clinical research and Paul Schwartz executive director, licensing and business development.

Crucell NV, of Leiden, the Netherlands, appointed Jean-Yves Guichoux executive vice president, development.

DeNovo Pharmaceuticals Ltd., of Cambridge, UK, announced Bart Wuurman will be CEO. Mike Ashton will become chairman, replacing Alan Goodman, who remains a board member.

Immunicon Corp., of Huntington Valley, Pa., appointed Allen Lauer to its board.

Lexicon Genetics Inc., of the Woodlands, Texas, elected Alan Nies to its board.

Marligen Biosciences Inc., of Ijamsville, Md., added James Chamberlain to its board.

Maxim Pharmacueticals Inc., of San Diego, said Wayne Yetter joined its board as independent director.

MGI Pharma Inc., of Minneapolis, added Edward Rubenstein as senior vice president, medical and commercial development.

Pain Therapeutics Inc., of South San Francisco, said Vernon Loucks joined its board.

Perlegen Sciences Inc., of Mountain View, Calif., said Robert Middlebrook joined the company as chief corporate development officer.

Protein Mechanics Inc., of Mountain View, Calif., said Irwin Kuntz joined its scientific advisory board.

ProtoKinetix Inc., of Vancouver, British Columbia, said Jean-Marie Dupuy joined its scientific advisory board.

PTC Therapeutics Inc., of South Plainfield, N.J., appointed Joseph Puglisi to its scientific advisory board.

StemCells Inc., of Palo Alto, Calif., appointed Barbara Araneo, Pedro Huertas and Nobuko Uchida to vice president of development, acting chief medical officer and vice president of stem cell biology, respectively.

Velcura Therapeutics Inc., of Ann Arbor, Mich., added Daniel Chagnovich, as senior scientist, bioinformatics.

Vicuron Pharmaceuticals Inc., of King of Prussia, Pa., added Lyn Wiesinger as senior vice president of marketing and market development.

Weill Cornell Medical College physician-scientists Flint Beal and Jean Pape were elected to the Institute of Medicine at the National Academy of Sciences.